Author： Huang Weng-Foung
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.29, Iss.3, 2006-01, pp. : 261-272
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Salvo Francesco Antoniazzi Stefania Duong Mai Molimard Mathieu Bazin Fabienne Fourrier-Réglat Annie Pariente Antoine Moore Nicholas
Expert Opinion on Drug Safety, Vol. 13, Iss. 5, 2014-05 ,pp. :
Access to resources
Recommend
Celecoxib associated with similar cardiovascular risk to rofecoxib
Reactions Weekly, Vol. 1, Iss. 1048, 2005-01 ,pp. :
Celecoxib and rofecoxib ADRs compared with meloxicam
Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. :
Factors associated with celecoxib, rofecoxib use in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 479, 2005-01 ,pp. :
Renal Failure Associated with the Use of Celecoxib and Rofecoxib
By Ahmad S.R. Kortepeter C. Brinker A. Chen M. Beitz J.
Drug Safety, Vol. 25, Iss. 7, 2002-01 ,pp. :